Skip to main content

Search
Profile

Aaron K. Olson, MD

|
Aaron K. Olson, MD

Cardiology

On staff since July 2006

Academic Title: Assistant Professor, Division of Cardiology, Department of Pediatrics

Research Center: Center for Developmental Therapeutics

"I go to work each day striving to make new discoveries in the basic science mechanisms controlling cardiovascular disease in children. I hope to translate these discoveries into new therapies for pediatric patients. "

Overview

Board Certification(s)
Pediatrics
Pediatric Cardiology
Medical/Professional School
University of Minnesota , Minneapolis
University of Minnesota - Duluth School of Medicine, Duluth
Residency
Pediatrics, University of Chicago , Chicago
Fellowship
Pediatric Cardiology, University of Iowa Hospitals and Clinics, Iowa City
Pediatric Cardiology, University of Iowa Hospitals and Clinics, Iowa City
Clinical Interests

Neonatal heart disease

Research Focus Area

Cardiac Metabolism, Kawasaki Disease, Cardiac Hypertrophy, Genetic Cardiovascular Disease

Publications

Prospective open-label trial of etanercept as adjunctive therapy for kawasaki disease.
The Journal of pediatrics , 2010 Dec: 960-966.e1
Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis.
Circulation , 2010 Sep 14: S224-33
Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis.
Circulation , 2010 Sep 14: S224-33
Prospective Open-Label Trial of Etanercept as Adjunctive Therapy for Kawasaki Disease.
The Journal of pediatrics , 2010 Jul 26
Superior cardiac function via anaplerotic pyruvate in the immature swine heart after cardiopulmonary bypass and reperfusion.
American journal of physiology. Heart and circulatory physiology , 2008 Dec: H2315-20
Cardioselective dominant-negative thyroid hormone receptor (Delta337T) modulates myocardial metabolism and contractile efficiency.
American journal of physiology. Endocrinology and metabolism , 2008 Aug: E420-7
Activation of the mitogen-activated protein kinases and Akt in response to pulmonary artery banding in the fetal sheep heart is developmentally regulated.
Neonatology , 2008: 145-52
The mitogen-activated protein kinases and Akt are developmentally regulated in the chronically anemic fetal sheep heart.
Journal of the Society for Gynecologic Investigation , 2006 Apr: 157-65
Mitogen-activated protein kinase activation and regulation in the pressure-loaded fetal ovine heart.
American journal of physiology. Heart and circulatory physiology , 2006 Apr: H1587-95

Presentations

Presentations TitleEventLocationDate
Metabolic Substrate Utilization During C-Myc Induced Cardiac HypertrophyJuly 1, 2009

Research Funding

Grant TitleGrantorAmountAward Date
The Marfan Trial- a Trial of Beta Blocker Therapy (Atenolol) vs. Angiotensin II Receptor Blocker Therapy (Losartan) in individuals with Marfan syndrome (MFS)National Institute of Health $unknownFeb. 1, 2008
Role of Fcgamma Receptor Polymorphisms in Determining IVIG Response in Kawasaki DiseaseThrasher FoundationJan. 1, 2008
a somewhat long titlesteve $1241685484July 16, 1984